Lumexa Imaging HoldingsLMRI +14.37%8 9-Day RSI is 83.07 as of Jun. 28, 2026. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 871 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 99.08% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Lumexa Imaging Holdings 9-Day RSI Related Terms
LMRI vs SSII, CBLL, AVR: 9-Day RSI Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a 9-Day RSI of 83.07 as of Jun. 28, 2026. According to the industry distribution chart, Lumexa Imaging Holdings ranks #863 out of 871 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Lumexa Imaging Holdings' 9-Day RSI too high?
Lumexa Imaging Holdings' current 9-Day RSI is 83.07. The Medical Devices & Instruments industry median 9-Day RSI is 42.68. Lumexa Imaging Holdings' value of 83.07 is 94.6% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #863 out of 871 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' 9-Day RSI compare to SSII and CBLL?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #863 out of 871 companies for 9-Day RSI. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median 9-Day RSI is 42.68. Lumexa Imaging Holdings' value of 83.07 is 94.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 42.68, based on 871 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current 9-Day RSI of 83.07 is 94.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 42.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current 9-Day RSI is 83.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current 9-Day RSI of 83.07. The current 9-Day RSI is 83.07 and 94.6% above the Medical Devices & Instruments industry median of 42.68. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current 9-Day RSI is 83.07 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 